Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1197

HEXYLCAINE
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
CC(CNC1CCCCC1)OC(=O)c1ccccc1

Basic Information

ChEMBL ID CHEMBL1197
Name HEXYLCAINE
Phase Approved
Structure Type MOL
InChI Key DKLKMKYDWHYZTD-UHFFFAOYSA-N
Therapeutic ✓ Yes

Known Names

Hexilcaina Hexylcaine Osmocaine
2
Targets
3
Activities
1
Assay Types
0
PK Parameters
7
Publications
3
Known Names

Molecular Properties

261.4
MW (Da)
3.15
ALogP
3
HBA
1
HBD
38.3
PSA (Ų)
0.83
QED
0
Ro5 Violations
5
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1982
Availability Discontinued
Chirality Racemic

Routes of Administration

Topical

Flags

Natural Product
USAN Stem -caine

Extended Properties

Molecular Formula C16H23NO2
MW 261.36
Aromatic Rings 1
Heavy Atoms 19
NP-Likeness -0.24

Activity Summary

IC50 3 meas. best 5.16

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Sodium channel alpha subunits; brain (Types I, II, III)
CHEMBL2096682
IC50 5.16 5.16 7000.0 1
Unchecked
CHEMBL612545
IC50 5.15 5.15 7079.5 2

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
2579237 10.1021/jm00381a019 Sodium channel alpha subunits; brain (Types I, II, III) 2
19346132 10.1016/j.bmc.2008.10.031 Unchecked 2
- 10.6019/CHEMBL4651402 SARS-CoV-2 2
- 10.6019/CHEMBL4808148 Histone deacetylase 6 2
19346132 10.1016/j.bmc.2008.10.031 No relevant target 1
- 10.1101/2020.04.21.054387 SARS-CoV-2 1
38318365 10.1016/j.isci.2024.108907 Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 1

Data from ChEMBL 36 via Core Engine